During the past decade, Lin Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lin Medical Center" #1 sponsor was "Carmel Medical Center" with 6 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Cellectar Biosciences, Inc." with 1 trials sponsored and "Clalit Health Services" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lin Medical Center" #1 collaborator was "Carmel Medical Center" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Lin Medical Center" are "Diabetes Mellitus, Type 2" (2 trials), "Osteoporosis" (2 trials), "Quality of Life" (2 trials), "Accuracy of the SofTouch Device Measuring Blood Glucose and Other Parameters" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Lin Medical Center" in a lesser frequency.

Most popular intervention types in "Lin Medical Center" are "Drug" (9 trials), "Device" (2 trials), "Dietary Supplement" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Dulaglutide" (2 trials), "Placebo" (2 trials), "ALX1-11" (1 trials) and "ALX1-11 (drug)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lin Medical Center" are 13 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Lin Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Lin Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lin Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".